AGF Investments Inc. increased its position in Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) by 87.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,862 shares of the biopharmaceutical company’s stock after acquiring an additional 2,262 shares during the period. AGF Investments […]